Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Swiftmerge Acquisition A | IVCP | Nov 19, 2024 | 11.07 | 0.00 |
Swiftmerge Acquisition Unit | IVCPU | Nov 19, 2024 | 11.10 | 0.00 |
Swiss Franc Trust | FXF | Nov 19, 2024 | 100.69 | +0.11 |
Swiss Helvetia Fund | SWZ | Nov 19, 2024 | 7.81 | -0.89 |
Switzerland Alphadex First Trust | FSZ | Nov 19, 2024 | 64.88 | +0.05 |
Switzerland Index MSCI Ishares | EWL | Nov 19, 2024 | 47.20 | -0.53 |
SWK Holdings | SWKH | Nov 19, 2024 | 15.36 | -2.78 |
Swvl Holdings A | SWVL | Nov 19, 2024 | 6.67 | +11.17 |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | Nov 19, 2024 | 1.71 | +5.56 |
Sylvamo | SLVM | Nov 19, 2024 | 86.70 | +1.38 |
Symbotic | SYM | Nov 19, 2024 | 39.02 | +27.68 |
Synaptics | SYNA | Nov 19, 2024 | 72.69 | -1.57 |
Synaptogenix | SNPX | Nov 19, 2024 | 2.41 | -4.37 |
Synchronoss Technologies | SNCR | Nov 19, 2024 | 8.98 | +2.86 |
Synchrony Financial | SYF | Nov 19, 2024 | 63.65 | -0.62 |
Synchrony Financial Pref A | SYF-A | Nov 19, 2024 | 20.27 | -0.17 |
Synchrony Financial Pref A | SYF-B | Nov 19, 2024 | 26.05 | -0.19 |
Syndax Pharmaceuticals | SNDX | Nov 19, 2024 | 15.77 | -2.11 |
Synergetics Inc | FTGC | Nov 19, 2024 | 23.69 | +0.30 |
Synergy CHC | SNYR | Nov 19, 2024 | 5.90 | 0.00 |
Synlogic | SYBX | Nov 19, 2024 | 1.36 | -0.73 |
Synopsys | SNPS | Nov 19, 2024 | 534.02 | +1.92 |
Synovus Financial | SNV | Nov 19, 2024 | 55.19 | -1.31 |
Synovus Financial D Pref | SNV-D | Nov 19, 2024 | 25.33 | 0.00 |
Synovus Financial E Pref | SNV-E | Nov 19, 2024 | 26.35 | -0.15 |
Syntec Optics | OPTX | Nov 19, 2024 | 0.92 | -7.22 |
Sypris Solutions | SYPR | Nov 19, 2024 | 1.40 | 0.00 |
Syra Health | SYRA | Nov 19, 2024 | 0.38 | +4.15 |
Syros Pharmaceuticals | SYRS | Nov 19, 2024 | 0.28 | +39.24 |
Sysco | SYY | Nov 19, 2024 | 74.40 | -1.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.